Gelonghui, April 23 | According to the Science and Technology Innovation Board Daily, we learned at the special insulin procurement site on the 23rd that the prices for the subsequent procurement of Tonghua Dongbao human insulin injection, sperm protein human insulin mixed injection (30R), mendong insulin injection, insulin glargine injection, and Mendong insulin 30 injection were all bid. The prices for the 6 products corresponding to the 3ml:300 unit (refill) specifications were 25.93 yuan, 25.93 yuan, 25.93 yuan, respectively. 23.98 yuan, 63.33 yuan, 23.98 yuan. Among them, the first 5 products were all lowered compared to the previous collection, while Mendong 30 insulin participated in the collection for the first time and won the bid at the lowest price. The price was lower than that of Ganli Pharmaceutical and Federal Pharmaceuticals.
通化东宝胰岛素接续采购6个竞标产品全部中标 价格下调
Tonghua Dongbao Insulin successively purchased 6 competitive products and lowered the bid prices for all
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.